Norgestrel and Ethinyl Estradiol (Ovral)

Category:

  • Hormone

Description:

  • Monophasic oral contraceptive

  • Ovral: norgestrel 0.5mg, ethinyl estradiol 50mcg

Indications:

  • Contraceptive

Contraindications:

  • Pregnancy

  • Undiagnosed abnormal vaginal bleeding

  • Known or suspected benign or malignant liver tumors while on oral contraceptive use

  • Breast carcinoma or estrogen-dependent neoplasia
  • Current or history of thromboembolic disorders, cerebral vascular or cardiovascular disease.

Precautions:

  • Pregnancy category X

  • Take as directed at intervals not exceeding 24 hours.  Efficiency is dependent upon strict compliance.

  • Breakthrough bleeding (“spotting”) may occur during initiation of therapy.

  • OCPs are 99.9% effective after the 1st month, if taken according to the prescribed schedule. 

  • During the first month, effectiveness depends on how many OCPs have been taken, but overall are about 95% effective, comparable to condoms or a diaphragm.

  • Instructions for missed doses:

  • One missed dose: Take as soon as possible or two tablets the next day and continue

  • Two missed doses: Take two tablets daily for two days, then continue normal schedule

  • Three missed doses: Discontinue therapy and begin new packet 7 days following last dose

  • May cause mental depression, fluid retention and depressed folate levels

  • Twenty-eight day packs contain seven days of inert ingredients to maintain regimen

Adverse Reactions (Side Effects):

  • Abdominal cramping, anorexia, nausea, vomiting

  • Acne (Usually makes it better)

  • Breast tenderness

  • Edema, weight gain

  • Unusual tiredness or weakness

  • Cardiovascular disorders (hypertension)

  • Thromboembolic disorders  

Dosage:

  • Administered orally

  • One tablet daily for 21 or 28 days beginning on the:

    • Fifth day of the cycle, or

    • First Sunday after the beginning of flow

For more information on Oral Contraceptive Pills, read:

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300  


OB-GYN 101: Introductory Obstetrics & Gynecology
© 2003, 2004, 2005 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

Contents · Introduction · Learning Objectives · Clinical Issues · Procedures  · Library · Pharmacy · Lab · Chest X-ray · Ultrasound · Videos · Forms · Progress Notes · Facts Cards · Students · Search · Feedback · About Us